Aprepitant: Clinical Trials

1 trial of Aprepitant, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Terminated 1

Follow Aprepitant: new trials by email Literature Review of Aprepitant trials Research Report on Aprepitant

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of MK-0869 (Aprepitant) and MK-0517 (Fosaprepitant) in Pediatric Participants Receiving Chemotherapy (MK-0869-134)
Experimental: aprepitant, Experimental: fosaprepitant, Comparator: ondansetron - Chemotherapy-Induced Nausea and Vomiting
Phase 1TerminatedMerck Sharp & Dohme LLC922009-02-052018-09-25

Conditions studied

Vomiting (1)

Sponsors

Merck Sharp & Dohme LLC (1)

Results publications

PMID 25770814